Cargando…
Use of rituximab, temozolomide, and radiation in recurrent and refractory primary central nervous system lymphoma in the Philippines: a retrospective analysis
BACKGROUND: Refractory disease in primary central nervous system lymphoma (PCNSL) may occur despite adequate initial treatment. There is currently no standard of care for relapsed and recurrent PCSNL. No study to date documents using a combined regimen of radiotherapy, temozolomide, and rituximab. T...
Autores principales: | Batara, Julette Marie F, Apor, Almira Doreen Abigail O, Mojica, Christianne V, Mondia, Mark Willy L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307100/ https://www.ncbi.nlm.nih.gov/pubmed/35892049 http://dx.doi.org/10.1093/noajnl/vdac105 |
Ejemplares similares
-
Neuro-oncology in the Philippines: a scoping review on the state of medical practice, deterrents to care and therapeutic gaps
por: Mondia, Mark Willy L, et al.
Publicado: (2021) -
On optimal temozolomide scheduling for slowly growing glioblastomas
por: Segura-Collar, Berta, et al.
Publicado: (2022) -
Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma
por: Fujimoto, Kenji, et al.
Publicado: (2020) -
Pharmacokinetic properties of the temozolomide perillyl alcohol conjugate (NEO212) in mice
por: Cho, Hee-Yeon, et al.
Publicado: (2020) -
Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
por: Murakami, Mineko, et al.
Publicado: (2011)